The Centre’s plan to install rooftop solar panels in 75 lakh households by year-end may hit a few bumps due to the limited availability and rising costs of these panels made from domestically- ...
The Vertex N Shield solar panel from Trinasolar is now available to the North American market. The 620-W Vertex N Shield with 23% efficiency is engineered to withstand the extreme weather and common ...
A group of researchers from the University of New South Wales (UNSW) in Australia and Chinese PV manufacturer Trina Solar have designed a silver-free silicon (Si) tunnel oxide passivated back contact ...
In related news from Trinasolar, the manufacturer signed an MoU to distribute 600MW of its Vertex N G3 modules. Image: Trinasolar. Solar manufacturer Trinasolar has reached a record peak power output ...
A group of solar manufacturers and developers has approached the Karnataka High Court to defer a rule that, from June 1, requires most new solar projects to use only domestically made cells. They cite ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: iStock A Pennsylvania homeowner's solar panels had a great energy production day, and their post about it drew a few ...
Japanese solar brand Toyo Solar announced it is building a 1.5-GW HJT solar cell manufacturing facility co-located at its existing module assembly site in Houston, Texas. The new cell factory is ...
Want to bring your coffeemaker camping or run your jigsaw off-grid? You can do that with a portable solar power system. My partner and I are on an international quest to uncover the mysteries of ...
2026 SNEC Exhibition: A New Era of 700W+ and Scenario-Specific PV Modules From June 3 to 5, the 2026 SNEC exhibition was held as scheduled. EnergyTrend’s observation and exploration of the event ...
Recently, Trina Solar and CECEP Solar Energy successively disclosed their latest operational and development plans, answering key questions of interest to investors. According to information disclosed ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
A multicenter, randomized, controlled, open-label, phase II trial of autologous tumor-infiltrating lymphocytes (GC101 TIL) in patients with advanced melanoma. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results